141 related articles for article (PubMed ID: 7640037)
1. Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer.
Gion M; Mione R; Dittadi R; Romanelli M; Pappagallo L; Capitanio G; Friede U; Barbazza R; Visonà A; Dante S
Eur J Cancer; 1995; 31A(5):671-7. PubMed ID: 7640037
[TBL] [Abstract][Full Text] [Related]
2. Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors.
Marsigliante S; Biscozzo L; Correale M; Paradiso A; Leo G; Abbate I; Dragone CD; Storelli C
Br J Cancer; 1994 Mar; 69(3):550-4. PubMed ID: 8123486
[TBL] [Abstract][Full Text] [Related]
3. [The prognostic significance of cathepsin D in primary breast cancer].
Crombach G; Ingenhorst A; Göhring UJ; Scharl A; Schaeffer HJ; Stützer H; Bolte A
Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):545-51. PubMed ID: 8001750
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin-D in human breast cancer: correlation with vascular invasion and other clinical and histopathological characteristics.
Hähnel R; Harvey J; Robbins P; Sterrett G
Anticancer Res; 1993; 13(6A):2131-5. PubMed ID: 8297125
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis.
Foekens JA; van Putten WL; Portengen H; de Koning HY; Thirion B; Alexieva-Figusch J; Klijn JG
J Clin Oncol; 1993 May; 11(5):899-908. PubMed ID: 8487052
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.
Göhring UJ; Scharl A; Thelen U; Ahr A; Crombach G; Titius BR
J Clin Pathol; 1996 Jan; 49(1):57-64. PubMed ID: 8666688
[TBL] [Abstract][Full Text] [Related]
7. [The prognostic value of cathepsin D concentration in cytosol of primary breast carcinoma].
Bussen S; Rempen A; Caffier H
Zentralbl Gynakol; 1995; 117(5):253-9. PubMed ID: 7793167
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients.
Foekens JA; Look MP; Bolt-de Vries J; Meijer-van Gelder ME; van Putten WL; Klijn JG
Br J Cancer; 1999 Jan; 79(2):300-7. PubMed ID: 9888472
[TBL] [Abstract][Full Text] [Related]
9. [Cathepsin D in primary breast cancer in correlation with various prognostic factors].
Rempen A; Caffier H
Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):272-5. PubMed ID: 1650323
[TBL] [Abstract][Full Text] [Related]
10. PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.
Gion M; Mione R; Pappagallo GL; Gatti C; Nascimben O; Bari M; Leon AE; Vinante O; Bruscagnin G
Br J Cancer; 1993 Aug; 68(2):374-9. PubMed ID: 8347494
[TBL] [Abstract][Full Text] [Related]
11. Expression of cathepsin D in malignant and in the corresponding non-malignant node-negative laryngeal samples: correlation with receptors for androgen, glucocorticoid, oestrogen and progesterone.
Marsigliante S; Resta L; Leo G; Mazzotta D; d'Amore R; Biscozzo L; Storelli C
Cancer Lett; 1993 Feb; 68(2-3):135-42. PubMed ID: 8443785
[TBL] [Abstract][Full Text] [Related]
12. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.
Thorpe SM; Rochefort H; Garcia M; Freiss G; Christensen IJ; Khalaf S; Paolucci F; Pau B; Rasmussen BB; Rose C
Cancer Res; 1989 Nov; 49(21):6008-14. PubMed ID: 2790815
[TBL] [Abstract][Full Text] [Related]
13. Relation of cathepsin D level to the estrogen receptor in human breast cancer.
Marsigliante S; Biscozzo L; Greco S; Leo G; Storelli C
Int J Clin Lab Res; 1992; 22(1):52-7. PubMed ID: 1633322
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer.
Rodríguez J; Vázquez J; Corte MD; Lamelas M; Bongera M; Corte MG; Alvarez A; Allende M; Gonzalez L; Sánchez M; Vijande M; Garcia Muñiz J; Vizoso F
Int J Biol Markers; 2005; 20(2):103-11. PubMed ID: 16011040
[TBL] [Abstract][Full Text] [Related]
15. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of thymidine kinase and cathepsin D in 200 primary breast carcinomas.
Greco S; Marsigliante S; Leo G; Storelli C
Cancer Lett; 2000 Nov; 160(1):13-9. PubMed ID: 11098079
[TBL] [Abstract][Full Text] [Related]
17. [Cathepsin D expression in primary breast cancer. Comparison of immunohistochemical and biochemical results].
Göhring UJ; Ingenhorst A; Crombach G; Scharl A
Pathologe; 1993 Dec; 14(6):313-7. PubMed ID: 8121884
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin D: association between TN-stage and steroid receptor status of breast carcinoma.
Nikolić-Vukosavljević D; Grujić-Adanja G; Nastić-Mirić D; Branković-Magić M; Jovanović D; Polić D; Mitrović L
Tumour Biol; 1998; 19(5):329-34. PubMed ID: 9701723
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group.
Fernö M; Baldetorp B; Borg A; Brouillet JP; Olsson H; Rochefort H; Sellberg G; Sigurdsson H; Killander D
Eur J Cancer; 1994; 30A(14):2042-8. PubMed ID: 7857700
[TBL] [Abstract][Full Text] [Related]
20. [Cathepsin D: an independent prognostic factor in cancer of the breast].
Romain S; Muracciole X; Varette I; Bressac C; Brandone H; Martin PM
Bull Cancer; 1990; 77(5):439-47. PubMed ID: 2400813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]